OCULAR THERAPEUTIX, INC (OCUL)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch OCUL
See up to 3 months of OCUL. The 7-day demo opens the 1M and 3M ranges and puts OCUL on your watchlist.
Start 7-day demoLatest OCUL insider trades
Todd Anderman - OfficerOpen-market sale$87K- Peter Kaiser - Officer
About OCULAR THERAPEUTIX, INC (OCUL)
The SEC lists OCULAR THERAPEUTIX, INC under CIK 0001393434, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
OCUL Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 8 | 63,819 | $568K |
| Bona-fide gift | 2 | 100,184 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
OCUL insider transactions (Form 4)
4261 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Pravin Dugel - Officer | Open-market sale | Common Stock | 124,882 footnote F1 | $9.04 footnote F2 | $1.13M | |
| ||||||
 Nadia Waheed - Officer | Open-market sale | Common Stock | 7,863 footnote F1 | $9.04 footnote F2 | $71K | |
| ||||||
 Donald Notman - Officer | Open-market sale | Common Stock | 5,455 footnote F1 | $9.14 footnote F2 | $50K | |
| Donald Notman - Officer | Open-market sale | Common Stock | 6,035 footnote F3 | $8.54 footnote F4 | $52K | |
| ||||||
 David Wayne Robinson - Officer | Grant or award | Common Stock | 136,000 footnote F1 | $0.00 | - | |
| David Wayne Robinson - Officer | Grant or award | Stock Option (Right to Buy) | 416,000 | $0.00 | - | |
| ||||||
 Jason Shand Robins - Officer | Grant or award | Stock Option (Right to Buy) | 33,000 | $0.00 | - | |
| Sanjay Nayak - Officer | Open-market sale | Common Stock | 1,878 footnote F1 | $12.04 footnote F2 | $23K | |
| ||||||
| Pravin Dugel - Officer | Open-market sale | Common Stock | 19,530 footnote F1 | $12.04 footnote F2 | $235K | |
| Pravin Dugel - Officer | Gift | Common Stock | 49,754 | $0.00 | - | |
| Pravin Dugel - Officer | Gift | Common Stock | 49,754 | $0.00 | - | |
| ||||||
| Peter Kaiser - Officer | Open-market sale | Common Stock | 3,007 footnote F1 | $12.02 footnote F2 | $36K | |
| ||||||
 Jeffrey S. Heier - Officer | Open-market sale | Common Stock | 3,469 footnote F1 | $12.04 footnote F2 | $42K | |
| ||||||
| Namrata Saroj - Officer | Open-market sale | Common Stock | 25,865 footnote F1 | $10.74 footnote F2 | $278K | |
| ||||||
| Todd Anderman - Officer | Open-market sale | Common Stock | 11,132 footnote F1 | $12.34 footnote F2 | $137K | |
| ||||||
| Peter Kaiser - Officer | Open-market sale | Common Stock | 9,653 footnote F1 | $11.03 footnote F2 | $106K | |
| ||||||
| Jeffrey S. Heier - Officer | Open-market sale | Common Stock | 10,502 footnote F1 | $11.04 footnote F2 | $116K | |
| ||||||
| Pravin Dugel - Officer | Gift | Common Stock | 49,754 | $0.00 | - | |
| Pravin Dugel - Officer | Gift | Common Stock | 49,754 | $0.00 | - | |
| Donald Notman - Officer | Open-market sale | Common Stock | 1,066 | $12.43 | $13K | |
| Peter Kaiser - Officer | Open-market sale | Common Stock | 3,011 | $12.04 | $36K | |
| Sanjay Nayak - Officer | Open-market sale | Common Stock | 1,885 | $12.04 | $23K | |
| Jeffrey S. Heier - Officer | Open-market sale | Common Stock | 3,063 | $12.04 | $37K | |
| Pravin Dugel - Officer | Open-market sale | Common Stock | 21,494 | $12.04 | $259K | |
| Pravin Dugel - Officer | Gift | Common Stock | 200,332 | $0.00 | - | |
| Pravin Dugel - Officer | Gift | Common Stock | 50,029 | $0.00 | - | |
| Pravin Dugel - Officer | Gift | Common Stock | 250,361 | $0.00 | - | |
| Nadia Waheed - Officer | Grant or award | Common Stock | 40,363 | $0.00 | - | |
| Nadia Waheed - Officer | Grant or award | Stock Option (Right to Buy) | 122,923 | $0.00 | - | |
| Richard L. Md Lindstrom - Director | Grant or award | Common Stock | 14,000 | $0.00 | - | |
| Richard L. Md Lindstrom - Director | Grant or award | Stock Option (Right to Buy) | 44,000 | $0.00 | - | |
| Merilee Raines - Director | Grant or award | Common Stock | 14,000 | $0.00 | - | |
| Merilee Raines - Director | Grant or award | Stock Option (Right to Buy) | 44,000 | $0.00 | - | |
| Richard L. Md Lindstrom - Director | Open-market purchase | Common Stock | 10,000 | $6.96 | $70K | |
| Jeffrey S. Heier - Officer | Open-market sale | Common Stock | 2,948 | $9.01 | $27K | |
| Peter Kaiser - Officer | Open-market sale | Common Stock | 2,897 | $9.01 | $26K | |
| Sanjay Nayak - Officer | Open-market sale | Common Stock | 1,814 | $9.00 | $16K | |
| Pravin Dugel - Officer | Open-market sale | Common Stock | 20,680 | $9.01 | $186K | |
| Todd Anderman - Officer | Grant or award | Common Stock | 98,700 | $0.00 | - | |
| Todd Anderman - Officer | Grant or award | Stock Option (Right to Buy) | 296,500 | $0.00 | - | |
| Peter Kaiser - Officer | Grant or award | Common Stock | 100,000 | $0.00 | - | |
| Peter Kaiser - Officer | Grant or award | Stock Option (Right to Buy) | 200,000 | $0.00 | - | |
Item 2.02, 9.01
Item 5.02, 5.07, 9.01
Item 2.02, 9.01
Item 7.01
Recent OCUL Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| TODD ANDERMAN | Officer | 11,984 | $87K | View on EDGAR | |
| PETER KAZUO KAISER | Officer | 9,990 |
OCUL insider trading FAQ
What is the latest insider trade for OCUL?
OCULAR THERAPEUTIX, INC (OCUL) had 8 insider filings in the last 90 days, with the most recent on 2026-10-13. The full record for OCUL runs to 61 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying OCUL stock?
No insider purchases of OCUL were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling OCUL stock?
8 insider sales of OCUL were filed in the last 90 days, totaling $568K.
Where can I see OCUL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects OCUL Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Todd Anderman view on EDGAR
- - Peter Kaiser view on EDGAR
- - Jeffrey S. Heier view on EDGAR
- - Donald Notman view on EDGAR
- - Peter Kaiser view on EDGAR
- - Sanjay Nayak view on EDGAR
- - Jeffrey S. Heier view on EDGAR
- - Pravin Dugel view on EDGAR
- - Pravin Dugel view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where OCUL's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow OCUL with a 7-day demo
- OCUL on your watchlist
- Every OCUL Form 4 filing on record
- Up to 3 months of OCUL price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
